Target intelligence / Profile preview

Gastric lumen

Molecular classification
Other
01

Overview

The gastric lumen is the internal cavity of the stomach, serving as the primary site for the mechanical and chemical breakdown of food (StatPearls, NBK535425). It is characterized by an extremely acidic environment, typically maintaining a pH between 1 and 3, which is necessary for the activation of the proteolytic enzyme pepsin and the destruction of ingested microorganisms (Britannica, Stomach). While the lumen itself is an anatomical space rather than a specific molecular target like a receptor or enzyme, it serves as the functional compartment for various pharmacological interventions. For instance, antacids act directly within the gastric lumen to neutralize hydrochloric acid, while mucosal protective agents like sucralfate polymerize in the acidic luminal environment to coat ulcer sites (NCBI, Antacids). Additionally, the luminal environment plays a crucial role in the pharmacokinetics of oral drugs, as the low pH can significantly affect their ionization, solubility, and subsequent absorption (PubMed, 26003025). Pathological conditions such as peptic ulcers and gastroesophageal reflux disease are often managed by modulating the chemical composition of this space. Consequently, while not a protein target, the gastric lumen is a vital physiological compartment for therapeutic delivery and action.

Other names
Stomach cavityIntragastric spaceGastric cavityLumen of stomach
02

Mechanism of action

Drugs acting within the gastric lumen typically function through chemical neutralization of secreted hydrochloric acid, the formation of physical protective barriers over damaged mucosa, or the alteration of the surface tension of gas bubbles (StatPearls, NBK526049; NCBI, Antacids).

03

Biological functions

DigestionAcidificationProteolysisPathogen defenseMechanical processing of food
04

Disease associations

Peptic ulcer diseaseGastroesophageal reflux disease (GERD)GastritisHelicobacter pylori infectionZollinger-Ellison syndrome
05

Safety considerations

Altered absorption of co-administered drugs due to pH changesElectrolyte imbalances (e.g., hypercalcemia, hypomagnesemia)Acid rebound effectConstipation or diarrheaMilk-alkali syndrome
06

Interacting drugs

Calcium carbonate

5 more in the full profile.

07

Biomarkers

Gastric pHPepsin activityGastric volumeGastric emptying rate

Beyond the preview

Go deeper on Gastric lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call